163 related articles for article (PubMed ID: 24635863)
1. The clinical utility of biomarkers in the management of pancreatic adenocarcinoma.
Jazieh KA; Foote MB; Diaz LA
Semin Radiat Oncol; 2014 Apr; 24(2):67-76. PubMed ID: 24635863
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers in pancreatic cancer: diagnostic, prognostic, and predictive.
Fong ZV; Winter JM
Cancer J; 2012; 18(6):530-8. PubMed ID: 23187839
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic cancer: updates on translational research and future applications.
Sarris EG; Syrigos KN; Saif MW
JOP; 2013 Mar; 14(2):145-8. PubMed ID: 23474558
[TBL] [Abstract][Full Text] [Related]
4. Translational research. New findings and potential future applications in pancreatic adenocarcinoma.
Strimpakos AS; Syrigos KN; Saif MW
JOP; 2012 Mar; 13(2):177-9. PubMed ID: 22406595
[TBL] [Abstract][Full Text] [Related]
5. Adenocarcinoma of the pancreas--past, present and future.
Lygidakis NJ; Jain S; Sacchi M; Vrachnos P
Hepatogastroenterology; 2005; 52(64):1281-92. PubMed ID: 16001679
[TBL] [Abstract][Full Text] [Related]
6. [Serum tumor markers at exocrine adenocarcinoma of pancreas].
Holubec L; Finek J; Topolcan O; Svobodová S
Cas Lek Cesk; 2005; 144(2):86-8; discussion 89. PubMed ID: 15807292
[TBL] [Abstract][Full Text] [Related]
7. Major molecular markers in pancreatic ductal adenocarcinoma and their roles in screening, diagnosis, prognosis, and treatment.
Singh P; Srinivasan R; Wig JD
Pancreas; 2011 Jul; 40(5):644-52. PubMed ID: 21673535
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and therapeutic approach to pancreatic adenocarcinoma.
Germanos S; Gourgiotis S; Stavrothanasopoulou A; Alepas P; Zampitis N; Panteli A
J Gastrointestin Liver Dis; 2006 Sep; 15(3):257-63. PubMed ID: 17013451
[TBL] [Abstract][Full Text] [Related]
9. Hereditary factors in pancreatic cancer.
Lynch HT; Brand RE; Lynch JF; Fusaro RM; Kern SE
J Hepatobiliary Pancreat Surg; 2002; 9(1):12-31. PubMed ID: 12021894
[TBL] [Abstract][Full Text] [Related]
10. Investigational biomarkers for pancreatic adenocarcinoma: where do we stand?
Datta J; Vollmer CM
South Med J; 2014 Apr; 107(4):256-63. PubMed ID: 24937521
[TBL] [Abstract][Full Text] [Related]
11. Negative impact of fresh-frozen plasma transfusion on prognosis of pancreatic ductal adenocarcinoma after pancreatic resection.
Shiba H; Misawa T; Fujiwara Y; Futagawa Y; Furukawa K; Haruki K; Iida T; Iwase R; Yanaga K
Anticancer Res; 2013 Sep; 33(9):4041-7. PubMed ID: 24023348
[TBL] [Abstract][Full Text] [Related]
12. Current and future biomarkers for pancreatic adenocarcinoma.
Loosen SH; Neumann UP; Trautwein C; Roderburg C; Luedde T
Tumour Biol; 2017 Jun; 39(6):1010428317692231. PubMed ID: 28618958
[TBL] [Abstract][Full Text] [Related]
13. New frontiers in pancreatic cancer research.
Khan GN; di Magliano MP; Simeone DM
Surg Oncol Clin N Am; 2010 Apr; 19(2):431-51. PubMed ID: 20159524
[TBL] [Abstract][Full Text] [Related]
14. Clinical implications of biological markers in Pancreatic Ductal Adenocarcinoma.
Giovinazzo F; Turri G; Zanini S; Butturini G; Scarpa A; Bassi C
Surg Oncol; 2012 Dec; 21(4):e171-82. PubMed ID: 22981281
[TBL] [Abstract][Full Text] [Related]
15. Identification of prognostic and predictive markers in pancreatic adenocarcinoma. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011.
Russo SM; Ove R; Saif MW
JOP; 2011 Mar; 12(2):92-5. PubMed ID: 21386628
[TBL] [Abstract][Full Text] [Related]
16. Limitations in improving detection of pancreatic adenocarcinoma.
Mendieta Zerón H; García Flores JR; Romero Prieto ML
Future Oncol; 2009 Jun; 5(5):657-68. PubMed ID: 19519205
[TBL] [Abstract][Full Text] [Related]
17. Road to early detection of pancreatic cancer: Attempts to utilize epigenetic biomarkers.
Fukushige S; Horii A
Cancer Lett; 2014 Jan; 342(2):231-7. PubMed ID: 22450751
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and therapeutic approach to pancreatic cancer.
Barkin JS; Goldstein JA
Biomed Pharmacother; 2000 Aug; 54(7):400-9. PubMed ID: 10989980
[TBL] [Abstract][Full Text] [Related]
19. Molecular markers of early pancreatic cancer.
Goggins M
J Clin Oncol; 2005 Jul; 23(20):4524-31. PubMed ID: 16002843
[TBL] [Abstract][Full Text] [Related]
20. Tumor markers in pancreatic cancer. Sensitivity and specificity of CA 19-9.
Safi F; Roscher R; Beger HG
Hepatogastroenterology; 1989 Dec; 36(6):419-23. PubMed ID: 2613165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
